Geoffrey Dow: CEO of 60 Degrees Pharmaceuticals

Portrait of Geoffrey Dow

Geoffrey Dow, CEO of 60 Degrees Pharmaceuticals, shares his insights about leadership in biopharma and how 60 Degrees Pharmaceuticals is working to develop vital medicines to treat and prevent infectious diseases.

Acme United Annual Report detail
Acme United

Cutting Edge Technology

Psivant Employees in front of monitor with molecular model.
Psivant Therapeutics

Designing Better Therapeutics, Atom by Atom

Historical image of Shionogi employee in the lab.
Shionogi

140 Years